Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jun;118(3):585–592. doi: 10.1111/j.1476-5381.1996.tb15441.x

The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones.

J H Ryu 1, K Yanai 1, X L Zhao 1, T Watanabe 1
PMCID: PMC1909699  PMID: 8762081

Abstract

1. The binding of [3H]-(R)alpha-methylhistamine and [3H]-N alpha-methylhistamine to histamine H3-receptors, [3H]-SCH23390 to dopamine D1-receptors, and [3H]-YM09151-2 to dopamine D2-receptors was investigated by quantitative receptor autoradiography in the rat brain following 6-hydroxydopamine injection into the substantia nigra. 2. The levels of [3H]-(R)alpha-methylhistamine binding sites in the denervated striatum and substantia nigra were significantly higher than those in the contralateral side from 1 week to 12 weeks after nigral lesions. The H3-receptor binding was maximal at 3 weeks after nigral lesions and maintained until 12 weeks. 3. The increased number of histamine H3-receptors was decreased to the level of the contralateral side by chronic treatment with a selective dopamine D1 agonist, SKF38393, but not modified by a selective dopamine D2 agonist, quinpirole. 4. Dopamine D1- and D2-receptors in the striatum were similarly up-regulated after unilateral nigral lesion. On the other hand, the number of dopamine D2-receptors in the substantia nigra was markedly decreased after administration of 6-hydroxydopamine. 5. The treatment with (S)alpha-fluoromethylhistidine increased the H3-receptor binding in both the ipsilateral and contralateral sides. As a result, the magnitude of the ratio of the H3-receptor binding between ipsilateral and contralateral sides was partially attenuated by treatment with (S)-alpha-fluoromethylhistidine. 6. These results strongly suggest that the expression of histamine H3-receptors in the striatum and substantia nigra is influenced through D1-receptors by tonic nigrostriatal dopaminergic inputs.

Full text

PDF
585

Images in this article

586Figure 1
on p.586
587Figure 2
on p.587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariano M. A. Long-term changes in striatal D1 dopamine receptor distribution after dopaminergic deafferentation. Neuroscience. 1989;32(1):203–212. doi: 10.1016/0306-4522(89)90119-x. [DOI] [PubMed] [Google Scholar]
  2. Arrang J. M., Drutel G., Schwartz J. C. Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex. Br J Pharmacol. 1995 Apr;114(7):1518–1522. doi: 10.1111/j.1476-5381.1995.tb13379.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arrang J. M., Garbarg M., Lancelot J. C., Lecomte J. M., Pollard H., Robba M., Schunack W., Schwartz J. C. Highly potent and selective ligands for histamine H3-receptors. Nature. 1987 May 14;327(6118):117–123. doi: 10.1038/327117a0. [DOI] [PubMed] [Google Scholar]
  4. Barone P., Tucci I., Parashos S. A., Chase T. N. D-1 dopamine receptor changes after striatal quinolinic acid lesion. Eur J Pharmacol. 1987 Jun 12;138(1):141–145. doi: 10.1016/0014-2999(87)90351-7. [DOI] [PubMed] [Google Scholar]
  5. Cadet J. L., Zhu S. M. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat. Brain Res. 1992 Nov 13;595(2):316–326. doi: 10.1016/0006-8993(92)91066-n. [DOI] [PubMed] [Google Scholar]
  6. Clapham J., Kilpatrick G. J. Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol. 1994 Jul 1;259(2):107–114. doi: 10.1016/0014-2999(94)90498-7. [DOI] [PubMed] [Google Scholar]
  7. Creese I., Burt D. R., Snyder S. H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 1977 Aug 5;197(4303):596–598. doi: 10.1126/science.877576. [DOI] [PubMed] [Google Scholar]
  8. Cross A. J., Waddington J. L. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum. Eur J Pharmacol. 1981 May 8;71(2-3):327–332. doi: 10.1016/0014-2999(81)90035-2. [DOI] [PubMed] [Google Scholar]
  9. Cumming P., Shaw C., Vincent S. R. High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain. Synapse. 1991 Jun;8(2):144–151. doi: 10.1002/syn.890080208. [DOI] [PubMed] [Google Scholar]
  10. Engber T. M., Marin C., Susel Z., Chase T. N. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Eur J Pharmacol. 1993 Jun 4;236(3):385–393. doi: 10.1016/0014-2999(93)90476-x. [DOI] [PubMed] [Google Scholar]
  11. Fornaretto M. G., Caccia C., Caron M. G., Fariello R. G. Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain. Mol Chem Neuropathol. 1993 May-Jun;19(1-2):147–162. doi: 10.1007/BF03160175. [DOI] [PubMed] [Google Scholar]
  12. Gagnon C., Bédard P. J., Rioux L., Gaudin D., Martinoli M. G., Pelletier G., Di Paolo T. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat. Brain Res. 1991 Sep 6;558(2):251–263. doi: 10.1016/0006-8993(91)90776-r. [DOI] [PubMed] [Google Scholar]
  13. Geary W. A., 2nd, Toga A. W., Wooten G. F. Quantitative film autoradiography for tritium: methodological considerations. Brain Res. 1985 Jun 24;337(1):99–108. doi: 10.1016/0006-8993(85)91613-0. [DOI] [PubMed] [Google Scholar]
  14. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J., Jr, Sibley D. R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990 Dec 7;250(4986):1429–1432. doi: 10.1126/science.2147780. [DOI] [PubMed] [Google Scholar]
  15. Gnanalingham K. K., Robertson R. G. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study. Brain Res. 1994 Mar 21;640(1-2):185–194. doi: 10.1016/0006-8993(94)91872-4. [DOI] [PubMed] [Google Scholar]
  16. Heikkila R. E., Shapiro B. S., Duvoisin R. C. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats. Brain Res. 1981 May 4;211(2):285–292. doi: 10.1016/0006-8993(81)90614-4. [DOI] [PubMed] [Google Scholar]
  17. Hess E. J., Albers L. J., Le H., Creese I. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. J Pharmacol Exp Ther. 1986 Sep;238(3):846–854. [PubMed] [Google Scholar]
  18. Ichinose M., Stretton C. D., Schwartz J. C., Barnes P. J. Histamine H3-receptors inhibit cholinergic neurotransmission in guinea-pig airways. Br J Pharmacol. 1989 May;97(1):13–15. doi: 10.1111/j.1476-5381.1989.tb11917.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Itoh Y., Nishibori M., Oishi R., Saeki K. Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci Lett. 1984 Aug 10;48(3):305–309. doi: 10.1016/0304-3940(84)90055-7. [DOI] [PubMed] [Google Scholar]
  20. Jongen-Rêlo A. L., Docter G. J., Jonker A. J., Vreugdenhil E., Groenewegen H. J., Voorn P. Differential effects of dopamine depletion on the binding and mRNA levels of dopamine receptors in the shell and core of the rat nucleus accumbens. Brain Res Mol Brain Res. 1994 Sep;25(3-4):333–343. doi: 10.1016/0169-328x(94)90169-4. [DOI] [PubMed] [Google Scholar]
  21. Juncos J. L., Engber T. M., Raisman R., Susel Z., Thibaut F., Ploska A., Agid Y., Chase T. N. Continuous and intermittent levodopa differentially affect basal ganglia function. Ann Neurol. 1989 May;25(5):473–478. doi: 10.1002/ana.410250509. [DOI] [PubMed] [Google Scholar]
  22. LaHoste G. J., Marshall J. F. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse. 1992 Sep;12(1):14–26. doi: 10.1002/syn.890120103. [DOI] [PubMed] [Google Scholar]
  23. Mansour A., Meador-Woodruff J. H., Zhou Q., Civelli O., Akil H., Watson S. J. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 1992;46(4):959–971. doi: 10.1016/0306-4522(92)90197-a. [DOI] [PubMed] [Google Scholar]
  24. Marin C., Chase T. N. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation. Eur J Pharmacol. 1993 Feb 9;231(2):191–196. doi: 10.1016/0014-2999(93)90448-q. [DOI] [PubMed] [Google Scholar]
  25. Marshall J. F., Ungerstedt U. Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model. Eur J Pharmacol. 1977 Feb 21;41(4):361–367. doi: 10.1016/0014-2999(77)90256-4. [DOI] [PubMed] [Google Scholar]
  26. McGonigle P., Boyson S. J., Reuter S., Molinoff P. B. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 1989;3(1):74–82. doi: 10.1002/syn.890030111. [DOI] [PubMed] [Google Scholar]
  27. Nakagawa Y., Yanai K., Ryu J. H., Kiyosawa M., Tamai M., Watanabe T. Marked increase in [3H](R) alpha-methylhistamine binding in the superior colliculus of visually deprived rats after unilateral enucleation. Brain Res. 1994 Apr 18;643(1-2):74–80. doi: 10.1016/0006-8993(94)90010-8. [DOI] [PubMed] [Google Scholar]
  28. Panula P., Yang H. Y., Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572–2576. doi: 10.1073/pnas.81.8.2572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pollard H., Moreau J., Arrang J. M., Schwartz J. C. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience. 1993 Jan;52(1):169–189. doi: 10.1016/0306-4522(93)90191-h. [DOI] [PubMed] [Google Scholar]
  30. Porceddu M. L., Giorgi O., De Montis G., Mele S., Cocco L., Ongini E., Biggio G. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors. Life Sci. 1987 Aug 10;41(6):697–706. doi: 10.1016/0024-3205(87)90449-8. [DOI] [PubMed] [Google Scholar]
  31. Radja F., el Mansari M., Soghomonian J. J., Dewar K. M., Ferron A., Reader T. A., Descarries L. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience. 1993 Dec;57(3):635–648. doi: 10.1016/0306-4522(93)90011-4. [DOI] [PubMed] [Google Scholar]
  32. Rioux L., Gagnon C., Gaudin D. P., Di Paolo T., Bédard P. J. A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors. Neuroscience. 1993 Sep;56(1):45–51. doi: 10.1016/0306-4522(93)90560-3. [DOI] [PubMed] [Google Scholar]
  33. Rouillard C., Bédard P. J., Falardeau P., Dipaolo T. Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors. Neuropharmacology. 1987 Nov;26(11):1601–1606. doi: 10.1016/0028-3908(87)90008-6. [DOI] [PubMed] [Google Scholar]
  34. Ryu J. H., Yanai K., Iwata R., Ido T., Watanabe T. Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat brain. Neuroreport. 1994 Jan 31;5(5):621–624. doi: 10.1097/00001756-199401000-00022. [DOI] [PubMed] [Google Scholar]
  35. Ryu J. H., Yanai K., Sakurai E., Kim C. Y., Watanabe T. Ontogenetic development of histamine receptor subtypes in rat brain demonstrated by quantitative autoradiography. Brain Res Dev Brain Res. 1995 Jul 14;87(2):101–110. doi: 10.1016/0165-3806(95)00055-i. [DOI] [PubMed] [Google Scholar]
  36. Ryu J. H., Yanai K., Watanabe T. Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study. Neurosci Lett. 1994 Aug 29;178(1):19–22. doi: 10.1016/0304-3940(94)90279-8. [DOI] [PubMed] [Google Scholar]
  37. Sakai N., Onodera K., Maeyama K., Yanai K., Watanabe T. Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv mice. Life Sci. 1991;48(25):2397–2404. doi: 10.1016/0024-3205(91)90373-j. [DOI] [PubMed] [Google Scholar]
  38. Savasta M., Dubois A., Benavides J., Scatton B. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat. Neurosci Lett. 1986 Dec 23;72(3):265–271. doi: 10.1016/0304-3940(86)90524-0. [DOI] [PubMed] [Google Scholar]
  39. Savasta M., Mennicken F., Chritin M., Abrous D. N., Feuerstein C., Le Moal M., Herman J. P. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience. 1992;46(3):729–738. doi: 10.1016/0306-4522(92)90159-y. [DOI] [PubMed] [Google Scholar]
  40. Schlicker E., Betz R., Göthert M. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):588–590. doi: 10.1007/BF00182737. [DOI] [PubMed] [Google Scholar]
  41. Schlicker E., Fink K., Detzner M., Göthert M. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm Gen Sect. 1993;93(1):1–10. doi: 10.1007/BF01244933. [DOI] [PubMed] [Google Scholar]
  42. Schlicker E., Fink K., Hinterthaner M., Göthert M. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):633–638. doi: 10.1007/BF00717738. [DOI] [PubMed] [Google Scholar]
  43. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl. 1971;367:69–93. doi: 10.1111/j.1365-201x.1971.tb11000.x. [DOI] [PubMed] [Google Scholar]
  44. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984 Mar 12;295(1):13–25. doi: 10.1016/0006-8993(84)90811-4. [DOI] [PubMed] [Google Scholar]
  45. Yanai K., Ryu J. H., Sakai N., Takahashi T., Iwata R., Ido T., Murakami K., Watanabe T. Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues. Jpn J Pharmacol. 1994 Jun;65(2):107–112. doi: 10.1254/jjp.65.107. [DOI] [PubMed] [Google Scholar]
  46. Yanai K., Ryu J. H., Watanabe T., Iwata R., Ido T. Receptor autoradiography with 11C and [3H]-labelled ligands visualized by imaging plates. Neuroreport. 1992 Nov;3(11):961–964. doi: 10.1097/00001756-199211000-00003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES